ZOMETA®:Treatment For Skeletal-Related Events From Bone Metastases-Worldwide Website Portal

View videos on bone
metastases and the ZOMETA
mechanism of action

Learn more about the ZOMETA(zoledronic acid) mechanism of action

For non-U.S. Healthcare Professionals: Get information about ZOMETA and its product characteristics

Learn more about ZOMETA product characteristics

zometa_map

ZOMETA Approved Countries

ZOMETA Not Approved Countries

Österreich	Brasil	Canada (English / Français)	中国
Danmark	Finlanden	France	Deutschland
日本	Nederland	Norge	Polska
Sverige	Schweiz	United States

Reference: 1. Data on file. Novartis Pharma AG.

Disclaimer: This is an international website for ZOMETA^® (zoledronic acid) and is intended for healthcare professionals outside the US. If you are a US resident, please click on the US flag at the top right corner of this page. The information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.